DEA Releases Fourth Temporary Extension of Telemedicine Flexibilities - paproviders.org
DEA has issued a fourth temporary extension of telemedicine flexibilities, continuing allowances for remote prescribing of controlled substances without an in-person exam.
Aforeworn detected this change in the Telehealth Cross-State Licensing space on August 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Telehealth platforms, virtual specialty clinics, behavioral-health providers, and e-prescribers that rely on DEA telemedicine flexibilities for controlled substance prescribing. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified in the source; the extension is temporary, so providers should stay alert for the next DEA update.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Telehealth Cross-State Licensing continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The DEA has extended the temporary telemedicine flexibilities for a fourth time, maintaining the current allowances for remote prescribing of controlled substances without an in-person medical evaluation.
Who it affects
Telehealth platforms, virtual specialty clinics, behavioral-health providers, and e-prescribers that rely on DEA telemedicine flexibilities for controlled substance prescribing.
What you must do
Continue to operate under the existing telemedicine flexibilities, but monitor for any changes in requirements or future announcements.
Deadline
Not specified in the source; the extension is temporary, so providers should stay alert for the next DEA update.
Never miss a change like this again
Aforeworn watches Telehealth Cross-State Licensing around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Telehealth Cross-State Licensing
- HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026 - southfloridahospitalnews.com
- US-CONGRESS BILLS-119hr10037ih: Virtual-Based Opioid Treatment for Veterans Act
- DEA Proposed Rules Address Telehealth Prescribing Post PHE - texmed.org
- Compact for Care: Texas Joins Interstate Agreement for Out-of-State Licensure - texmed.org
- DEA Extends Controlled Substance Prescribing via Telemedicine Through 2025 - texmed.org